GO:0005575 | cellular_component | 47.48% (113/238) | 1.25 | 0.0 | 0.0 |
GO:0008150 | biological_process | 55.46% (132/238) | 1.0 | 0.0 | 0.0 |
GO:0110165 | cellular anatomical entity | 41.6% (99/238) | 1.23 | 0.0 | 0.0 |
GO:0005634 | nucleus | 16.81% (40/238) | 2.18 | 0.0 | 0.0 |
GO:0065007 | biological regulation | 20.59% (49/238) | 1.86 | 0.0 | 0.0 |
GO:0050789 | regulation of biological process | 19.75% (47/238) | 1.9 | 0.0 | 0.0 |
GO:0003674 | molecular_function | 60.08% (143/238) | 0.76 | 0.0 | 0.0 |
GO:0005488 | binding | 44.54% (106/238) | 0.98 | 0.0 | 0.0 |
GO:0019222 | regulation of metabolic process | 15.13% (36/238) | 2.1 | 0.0 | 0.0 |
GO:0043226 | organelle | 23.53% (56/238) | 1.53 | 0.0 | 0.0 |
GO:0043229 | intracellular organelle | 23.53% (56/238) | 1.53 | 0.0 | 0.0 |
GO:0050794 | regulation of cellular process | 18.07% (43/238) | 1.84 | 0.0 | 0.0 |
GO:0031323 | regulation of cellular metabolic process | 14.71% (35/238) | 2.1 | 0.0 | 0.0 |
GO:0043231 | intracellular membrane-bounded organelle | 21.43% (51/238) | 1.61 | 0.0 | 0.0 |
GO:0043227 | membrane-bounded organelle | 21.43% (51/238) | 1.6 | 0.0 | 0.0 |
GO:0009889 | regulation of biosynthetic process | 13.87% (33/238) | 2.13 | 0.0 | 0.0 |
GO:0031326 | regulation of cellular biosynthetic process | 13.87% (33/238) | 2.13 | 0.0 | 0.0 |
GO:0060255 | regulation of macromolecule metabolic process | 14.29% (34/238) | 2.07 | 0.0 | 0.0 |
GO:0051171 | regulation of nitrogen compound metabolic process | 13.03% (31/238) | 2.17 | 0.0 | 0.0 |
GO:0019219 | regulation of nucleobase-containing compound metabolic process | 12.18% (29/238) | 2.25 | 0.0 | 0.0 |
GO:0080090 | regulation of primary metabolic process | 13.03% (31/238) | 2.16 | 0.0 | 0.0 |
GO:0051252 | regulation of RNA metabolic process | 11.76% (28/238) | 2.26 | 0.0 | 0.0 |
GO:0010468 | regulation of gene expression | 13.03% (31/238) | 2.08 | 0.0 | 0.0 |
GO:0010556 | regulation of macromolecule biosynthetic process | 13.03% (31/238) | 2.07 | 0.0 | 0.0 |
GO:0006355 | regulation of DNA-templated transcription | 10.5% (25/238) | 2.17 | 0.0 | 0.0 |
GO:2001141 | regulation of RNA biosynthetic process | 10.5% (25/238) | 2.17 | 0.0 | 0.0 |
GO:0005515 | protein binding | 19.33% (46/238) | 1.37 | 0.0 | 0.0 |
GO:0009987 | cellular process | 34.45% (82/238) | 0.9 | 0.0 | 0.0 |
GO:0032991 | protein-containing complex | 14.29% (34/238) | 1.63 | 0.0 | 0.0 |
GO:0048518 | positive regulation of biological process | 5.46% (13/238) | 3.08 | 0.0 | 0.0 |
GO:0051254 | positive regulation of RNA metabolic process | 4.2% (10/238) | 3.49 | 0.0 | 1e-06 |
GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | 4.2% (10/238) | 3.41 | 0.0 | 2e-06 |
GO:0006357 | regulation of transcription by RNA polymerase II | 5.04% (12/238) | 2.93 | 0.0 | 3e-06 |
GO:0051173 | positive regulation of nitrogen compound metabolic process | 4.62% (11/238) | 3.08 | 0.0 | 4e-06 |
GO:0009893 | positive regulation of metabolic process | 4.62% (11/238) | 3.06 | 0.0 | 4e-06 |
GO:0010604 | positive regulation of macromolecule metabolic process | 4.62% (11/238) | 3.06 | 0.0 | 4e-06 |
GO:0071840 | cellular component organization or biogenesis | 10.08% (24/238) | 1.77 | 0.0 | 6e-06 |
GO:0031325 | positive regulation of cellular metabolic process | 4.2% (10/238) | 3.14 | 0.0 | 8e-06 |
GO:0016043 | cellular component organization | 9.24% (22/238) | 1.8 | 1e-06 | 1.4e-05 |
GO:0048522 | positive regulation of cellular process | 4.2% (10/238) | 2.96 | 1e-06 | 2.4e-05 |
GO:0045893 | positive regulation of DNA-templated transcription | 3.36% (8/238) | 3.42 | 1e-06 | 2.8e-05 |
GO:1902680 | positive regulation of RNA biosynthetic process | 3.36% (8/238) | 3.42 | 1e-06 | 2.8e-05 |
GO:0003729 | mRNA binding | 4.2% (10/238) | 2.9 | 1e-06 | 3.3e-05 |
GO:0005829 | cytosol | 6.3% (15/238) | 2.15 | 2e-06 | 5.1e-05 |
GO:0008152 | metabolic process | 27.73% (66/238) | 0.79 | 4e-06 | 8.5e-05 |
GO:0044238 | primary metabolic process | 25.63% (61/238) | 0.83 | 4e-06 | 8.7e-05 |
GO:0051172 | negative regulation of nitrogen compound metabolic process | 2.94% (7/238) | 3.45 | 5e-06 | 0.000103 |
GO:0009891 | positive regulation of biosynthetic process | 3.36% (8/238) | 3.13 | 5e-06 | 0.000104 |
GO:0010557 | positive regulation of macromolecule biosynthetic process | 3.36% (8/238) | 3.13 | 5e-06 | 0.000104 |
GO:0031328 | positive regulation of cellular biosynthetic process | 3.36% (8/238) | 3.13 | 5e-06 | 0.000104 |
GO:0010558 | negative regulation of macromolecule biosynthetic process | 3.78% (9/238) | 2.84 | 6e-06 | 0.000132 |
GO:0045892 | negative regulation of DNA-templated transcription | 2.1% (5/238) | 4.3 | 7e-06 | 0.000135 |
GO:1902679 | negative regulation of RNA biosynthetic process | 2.1% (5/238) | 4.3 | 7e-06 | 0.000135 |
GO:0003676 | nucleic acid binding | 14.71% (35/238) | 1.16 | 7e-06 | 0.000144 |
GO:0031327 | negative regulation of cellular biosynthetic process | 3.78% (9/238) | 2.8 | 8e-06 | 0.000153 |
GO:0009890 | negative regulation of biosynthetic process | 3.78% (9/238) | 2.79 | 8e-06 | 0.000155 |
GO:0016071 | mRNA metabolic process | 3.78% (9/238) | 2.71 | 1.3e-05 | 0.000234 |
GO:0051253 | negative regulation of RNA metabolic process | 2.1% (5/238) | 4.09 | 1.3e-05 | 0.000246 |
GO:0010605 | negative regulation of macromolecule metabolic process | 3.78% (9/238) | 2.66 | 1.6e-05 | 0.000292 |
GO:0140513 | nuclear protein-containing complex | 5.88% (14/238) | 1.98 | 1.7e-05 | 0.000307 |
GO:0031324 | negative regulation of cellular metabolic process | 3.78% (9/238) | 2.64 | 1.8e-05 | 0.00032 |
GO:0009892 | negative regulation of metabolic process | 3.78% (9/238) | 2.63 | 1.9e-05 | 0.000328 |
GO:0071704 | organic substance metabolic process | 25.63% (61/238) | 0.75 | 2.5e-05 | 0.000422 |
GO:0003723 | RNA binding | 7.14% (17/238) | 1.7 | 2.7e-05 | 0.000444 |
GO:0022607 | cellular component assembly | 4.2% (10/238) | 2.38 | 2.8e-05 | 0.00046 |
GO:0005516 | calmodulin binding | 2.1% (5/238) | 3.86 | 2.9e-05 | 0.000462 |
GO:0097159 | organic cyclic compound binding | 24.37% (58/238) | 0.76 | 3e-05 | 0.000464 |
GO:0072594 | establishment of protein localization to organelle | 2.94% (7/238) | 3.04 | 2.8e-05 | 0.000466 |
GO:0006807 | nitrogen compound metabolic process | 21.43% (51/238) | 0.83 | 3.2e-05 | 0.000497 |
GO:0045184 | establishment of protein localization | 4.2% (10/238) | 2.33 | 3.9e-05 | 0.000601 |
GO:0004611 | phosphoenolpyruvate carboxykinase activity | 1.26% (3/238) | 5.52 | 4.3e-05 | 0.000646 |
GO:0033365 | protein localization to organelle | 2.94% (7/238) | 2.93 | 4.7e-05 | 0.000691 |
GO:0006886 | intracellular protein transport | 3.36% (8/238) | 2.65 | 5.2e-05 | 0.000747 |
GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 2.1% (5/238) | 3.68 | 5.2e-05 | 0.000755 |
GO:0070925 | organelle assembly | 2.1% (5/238) | 3.6 | 6.8e-05 | 0.000965 |
GO:0043933 | protein-containing complex organization | 4.2% (10/238) | 2.22 | 7.3e-05 | 0.001022 |
GO:0000993 | RNA polymerase II complex binding | 1.26% (3/238) | 5.24 | 7.6e-05 | 0.001054 |
GO:0043170 | macromolecule metabolic process | 19.33% (46/238) | 0.83 | 8.6e-05 | 0.001166 |
GO:0045944 | positive regulation of transcription by RNA polymerase II | 2.1% (5/238) | 3.53 | 8.6e-05 | 0.00117 |
GO:0046907 | intracellular transport | 4.2% (10/238) | 2.18 | 9.3e-05 | 0.001246 |
GO:0051641 | cellular localization | 5.04% (12/238) | 1.93 | 9.6e-05 | 0.001254 |
GO:0070727 | cellular macromolecule localization | 4.2% (10/238) | 2.17 | 9.8e-05 | 0.001258 |
GO:0033036 | macromolecule localization | 4.2% (10/238) | 2.17 | 9.9e-05 | 0.001263 |
GO:0008104 | protein localization | 4.2% (10/238) | 2.17 | 9.6e-05 | 0.001265 |
GO:0004612 | phosphoenolpyruvate carboxykinase (ATP) activity | 0.84% (2/238) | 7.05 | 0.000109 | 0.00135 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 1.68% (4/238) | 4.07 | 0.000108 | 0.001355 |
GO:0035770 | ribonucleoprotein granule | 1.68% (4/238) | 4.05 | 0.000114 | 0.001401 |
GO:0051649 | establishment of localization in cell | 4.2% (10/238) | 2.13 | 0.000123 | 0.00149 |
GO:0048523 | negative regulation of cellular process | 3.78% (9/238) | 2.26 | 0.000135 | 0.001622 |
GO:0043175 | RNA polymerase core enzyme binding | 1.26% (3/238) | 4.95 | 0.000138 | 0.00164 |
GO:0048519 | negative regulation of biological process | 3.78% (9/238) | 2.24 | 0.000154 | 0.001809 |
GO:0006094 | gluconeogenesis | 1.26% (3/238) | 4.84 | 0.000174 | 0.001999 |
GO:0019319 | hexose biosynthetic process | 1.26% (3/238) | 4.84 | 0.000174 | 0.001999 |
GO:0099080 | supramolecular complex | 2.52% (6/238) | 2.9 | 0.000181 | 0.002059 |
GO:0070063 | RNA polymerase binding | 1.26% (3/238) | 4.76 | 0.000205 | 0.0023 |
GO:0006397 | mRNA processing | 2.52% (6/238) | 2.83 | 0.000233 | 0.002591 |
GO:0015031 | protein transport | 3.36% (8/238) | 2.31 | 0.00025 | 0.002717 |
GO:0046364 | monosaccharide biosynthetic process | 1.26% (3/238) | 4.66 | 0.000248 | 0.002729 |
GO:0001098 | basal transcription machinery binding | 1.26% (3/238) | 4.58 | 0.000292 | 0.003111 |
GO:0001099 | basal RNA polymerase II transcription machinery binding | 1.26% (3/238) | 4.58 | 0.000292 | 0.003111 |
GO:0000122 | negative regulation of transcription by RNA polymerase II | 1.26% (3/238) | 4.5 | 0.000346 | 0.003652 |
GO:0016051 | carbohydrate biosynthetic process | 2.52% (6/238) | 2.71 | 0.000357 | 0.003733 |
GO:0009057 | macromolecule catabolic process | 3.78% (9/238) | 2.06 | 0.000365 | 0.003783 |
GO:0071763 | nuclear membrane organization | 0.84% (2/238) | 6.11 | 0.000403 | 0.004134 |
GO:0051234 | establishment of localization | 8.82% (21/238) | 1.18 | 0.000451 | 0.00458 |
GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 0.84% (2/238) | 6.02 | 0.00046 | 0.004629 |
GO:0140110 | transcription regulator activity | 5.04% (12/238) | 1.66 | 0.000527 | 0.005253 |
GO:0034063 | stress granule assembly | 0.84% (2/238) | 5.86 | 0.000571 | 0.005646 |
GO:0031124 | mRNA 3'-end processing | 1.26% (3/238) | 4.23 | 0.000595 | 0.005826 |
GO:0035091 | phosphatidylinositol binding | 1.68% (4/238) | 3.4 | 0.000625 | 0.006062 |
GO:0006996 | organelle organization | 4.62% (11/238) | 1.71 | 0.000659 | 0.006338 |
GO:0018105 | peptidyl-serine phosphorylation | 1.68% (4/238) | 3.36 | 0.000685 | 0.006468 |
GO:0018209 | peptidyl-serine modification | 1.68% (4/238) | 3.36 | 0.000685 | 0.006468 |
GO:1901564 | organonitrogen compound metabolic process | 14.71% (35/238) | 0.83 | 0.000695 | 0.006507 |
GO:0051179 | localization | 8.82% (21/238) | 1.13 | 0.000719 | 0.006674 |
GO:0016593 | Cdc73/Paf1 complex | 0.84% (2/238) | 5.66 | 0.000754 | 0.006932 |
GO:0009931 | calcium-dependent protein serine/threonine kinase activity | 1.26% (3/238) | 4.08 | 0.000797 | 0.007143 |
GO:0010857 | calcium-dependent protein kinase activity | 1.26% (3/238) | 4.08 | 0.000797 | 0.007143 |
GO:0003677 | DNA binding | 7.14% (17/238) | 1.28 | 0.000788 | 0.007189 |
GO:0004683 | calmodulin-dependent protein kinase activity | 1.26% (3/238) | 4.07 | 0.000817 | 0.007208 |
GO:0016070 | RNA metabolic process | 6.3% (15/238) | 1.38 | 0.000812 | 0.00722 |
GO:0016192 | vesicle-mediated transport | 3.36% (8/238) | 2.04 | 0.000869 | 0.007602 |
GO:0006139 | nucleobase-containing compound metabolic process | 9.66% (23/238) | 1.04 | 0.000945 | 0.008195 |
GO:0018193 | peptidyl-amino acid modification | 2.52% (6/238) | 2.41 | 0.001064 | 0.009155 |
GO:0000932 | P-body | 1.26% (3/238) | 3.82 | 0.001347 | 0.011499 |
GO:0043687 | post-translational protein modification | 3.78% (9/238) | 1.78 | 0.001426 | 0.012072 |
GO:0016570 | histone modification | 1.68% (4/238) | 3.07 | 0.001442 | 0.012114 |
GO:0019899 | enzyme binding | 2.1% (5/238) | 2.61 | 0.0015 | 0.012506 |
GO:0009056 | catabolic process | 5.04% (12/238) | 1.48 | 0.00152 | 0.012573 |
GO:0044237 | cellular metabolic process | 18.49% (44/238) | 0.66 | 0.001542 | 0.012656 |
GO:0000160 | phosphorelay signal transduction system | 1.26% (3/238) | 3.73 | 0.001596 | 0.012903 |
GO:0006810 | transport | 7.98% (19/238) | 1.11 | 0.001584 | 0.012904 |
GO:0016830 | carbon-carbon lyase activity | 1.68% (4/238) | 3.02 | 0.001619 | 0.012986 |
GO:0071705 | nitrogen compound transport | 3.78% (9/238) | 1.75 | 0.001671 | 0.013304 |
GO:0043130 | ubiquitin binding | 1.26% (3/238) | 3.66 | 0.001829 | 0.014454 |
GO:0072662 | protein localization to peroxisome | 0.84% (2/238) | 4.99 | 0.001883 | 0.014667 |
GO:0072663 | establishment of protein localization to peroxisome | 0.84% (2/238) | 4.99 | 0.001883 | 0.014667 |
GO:0003743 | translation initiation factor activity | 1.26% (3/238) | 3.63 | 0.001952 | 0.015097 |
GO:0035556 | intracellular signal transduction | 2.52% (6/238) | 2.23 | 0.001982 | 0.015217 |
GO:0035639 | purine ribonucleoside triphosphate binding | 10.08% (24/238) | 0.93 | 0.002019 | 0.015384 |
GO:0044877 | protein-containing complex binding | 2.94% (7/238) | 2.0 | 0.002053 | 0.015536 |
GO:0032182 | ubiquitin-like protein binding | 1.26% (3/238) | 3.59 | 0.002091 | 0.01571 |
GO:0046777 | protein autophosphorylation | 1.26% (3/238) | 3.58 | 0.002148 | 0.016025 |
GO:0046483 | heterocycle metabolic process | 9.66% (23/238) | 0.94 | 0.002283 | 0.016919 |
GO:0016462 | pyrophosphatase activity | 3.78% (9/238) | 1.68 | 0.002305 | 0.016965 |
GO:0005543 | phospholipid binding | 1.68% (4/238) | 2.86 | 0.002434 | 0.017664 |
GO:1901576 | organic substance biosynthetic process | 7.14% (17/238) | 1.12 | 0.002419 | 0.017677 |
GO:0004721 | phosphoprotein phosphatase activity | 1.68% (4/238) | 2.85 | 0.002459 | 0.017726 |
GO:0006006 | glucose metabolic process | 1.26% (3/238) | 3.5 | 0.002531 | 0.018124 |
GO:0016818 | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 3.78% (9/238) | 1.66 | 0.00258 | 0.018353 |
GO:0016817 | hydrolase activity, acting on acid anhydrides | 3.78% (9/238) | 1.64 | 0.002747 | 0.019408 |
GO:0009896 | positive regulation of catabolic process | 1.26% (3/238) | 3.44 | 0.002827 | 0.019845 |
GO:0006725 | cellular aromatic compound metabolic process | 9.66% (23/238) | 0.91 | 0.003031 | 0.02114 |
GO:1901575 | organic substance catabolic process | 4.62% (11/238) | 1.42 | 0.003127 | 0.021667 |
GO:0140694 | non-membrane-bounded organelle assembly | 1.26% (3/238) | 3.38 | 0.00318 | 0.021893 |
GO:0007034 | vacuolar transport | 1.26% (3/238) | 3.37 | 0.003217 | 0.022004 |
GO:0043328 | protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway | 0.84% (2/238) | 4.59 | 0.003247 | 0.022065 |
GO:0030015 | CCR4-NOT core complex | 0.84% (2/238) | 4.57 | 0.003307 | 0.022334 |
GO:0090304 | nucleic acid metabolic process | 7.98% (19/238) | 1.0 | 0.003573 | 0.023825 |
GO:0019538 | protein metabolic process | 11.34% (27/238) | 0.81 | 0.003563 | 0.023913 |
GO:0035459 | vesicle cargo loading | 0.84% (2/238) | 4.45 | 0.003909 | 0.025277 |
GO:0090110 | COPII-coated vesicle cargo loading | 0.84% (2/238) | 4.45 | 0.003909 | 0.025277 |
GO:0006368 | transcription elongation by RNA polymerase II | 0.84% (2/238) | 4.45 | 0.003909 | 0.025277 |
GO:0003824 | catalytic activity | 25.21% (60/238) | 0.48 | 0.003845 | 0.025327 |
GO:0016831 | carboxy-lyase activity | 1.26% (3/238) | 3.28 | 0.003827 | 0.025363 |
GO:0000209 | protein polyubiquitination | 1.26% (3/238) | 3.26 | 0.003965 | 0.025487 |
GO:0036211 | protein modification process | 9.24% (22/238) | 0.9 | 0.004076 | 0.025889 |
GO:0009058 | biosynthetic process | 7.14% (17/238) | 1.05 | 0.004063 | 0.025958 |
GO:0006354 | DNA-templated transcription elongation | 0.84% (2/238) | 4.38 | 0.004313 | 0.02707 |
GO:1901360 | organic cyclic compound metabolic process | 9.66% (23/238) | 0.87 | 0.004295 | 0.027117 |
GO:0009736 | cytokinin-activated signaling pathway | 0.84% (2/238) | 4.3 | 0.004808 | 0.029482 |
GO:0034641 | cellular nitrogen compound metabolic process | 9.66% (23/238) | 0.85 | 0.004726 | 0.029488 |
GO:0034654 | nucleobase-containing compound biosynthetic process | 2.94% (7/238) | 1.78 | 0.004782 | 0.029491 |
GO:0045927 | positive regulation of growth | 0.84% (2/238) | 4.3 | 0.004772 | 0.0296 |
GO:0140030 | modification-dependent protein binding | 0.84% (2/238) | 4.27 | 0.004954 | 0.029694 |
GO:0050779 | RNA destabilization | 0.84% (2/238) | 4.27 | 0.004954 | 0.029694 |
GO:0061157 | mRNA destabilization | 0.84% (2/238) | 4.27 | 0.004954 | 0.029694 |
GO:0005737 | cytoplasm | 6.72% (16/238) | 1.06 | 0.004873 | 0.029711 |
GO:0000045 | autophagosome assembly | 0.84% (2/238) | 4.26 | 0.005027 | 0.029801 |
GO:1905037 | autophagosome organization | 0.84% (2/238) | 4.26 | 0.005027 | 0.029801 |
GO:0031331 | positive regulation of cellular catabolic process | 0.84% (2/238) | 4.24 | 0.005214 | 0.030072 |
GO:0061014 | positive regulation of mRNA catabolic process | 0.84% (2/238) | 4.24 | 0.005214 | 0.030072 |
GO:0031055 | chromatin remodeling at centromere | 0.42% (1/238) | 7.6 | 0.005137 | 0.030114 |
GO:0034080 | CENP-A containing chromatin assembly | 0.42% (1/238) | 7.6 | 0.005137 | 0.030114 |
GO:0006378 | mRNA polyadenylation | 0.84% (2/238) | 4.24 | 0.005176 | 0.030182 |
GO:0030127 | COPII vesicle coat | 0.84% (2/238) | 4.21 | 0.005366 | 0.030452 |
GO:0000956 | nuclear-transcribed mRNA catabolic process | 1.26% (3/238) | 3.1 | 0.00543 | 0.030496 |
GO:0060090 | molecular adaptor activity | 1.26% (3/238) | 3.11 | 0.005346 | 0.030505 |
GO:0016197 | endosomal transport | 1.26% (3/238) | 3.1 | 0.005413 | 0.030562 |
GO:0017111 | ribonucleoside triphosphate phosphatase activity | 3.36% (8/238) | 1.61 | 0.00534 | 0.030636 |
GO:0035060 | brahma complex | 0.42% (1/238) | 7.49 | 0.005531 | 0.030896 |
GO:0042393 | histone binding | 1.26% (3/238) | 3.07 | 0.005722 | 0.031636 |
GO:0007031 | peroxisome organization | 0.84% (2/238) | 4.17 | 0.005714 | 0.031753 |
GO:0004842 | ubiquitin-protein transferase activity | 2.1% (5/238) | 2.15 | 0.005864 | 0.032251 |
GO:0140535 | intracellular protein-containing complex | 2.94% (7/238) | 1.72 | 0.006059 | 0.032649 |
GO:0010337 | regulation of salicylic acid metabolic process | 0.84% (2/238) | 4.13 | 0.006032 | 0.03267 |
GO:0080142 | regulation of salicylic acid biosynthetic process | 0.84% (2/238) | 4.13 | 0.006032 | 0.03267 |
GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway | 0.84% (2/238) | 4.13 | 0.006032 | 0.03267 |
GO:0004455 | ketol-acid reductoisomerase activity | 0.42% (1/238) | 7.3 | 0.006318 | 0.033877 |
GO:0043488 | regulation of mRNA stability | 0.84% (2/238) | 4.09 | 0.006358 | 0.033919 |
GO:0097367 | carbohydrate derivative binding | 11.34% (27/238) | 0.74 | 0.006434 | 0.033983 |
GO:1902494 | catalytic complex | 4.2% (10/238) | 1.36 | 0.006432 | 0.034144 |
GO:0070971 | endoplasmic reticulum exit site | 0.84% (2/238) | 4.07 | 0.006524 | 0.03429 |
GO:0030863 | cortical cytoskeleton | 0.42% (1/238) | 7.21 | 0.006712 | 0.034596 |
GO:0030864 | cortical actin cytoskeleton | 0.42% (1/238) | 7.21 | 0.006712 | 0.034596 |
GO:0061013 | regulation of mRNA catabolic process | 0.84% (2/238) | 4.05 | 0.006649 | 0.034609 |
GO:0031123 | RNA 3'-end processing | 1.26% (3/238) | 3.0 | 0.006635 | 0.034703 |
GO:0019787 | ubiquitin-like protein transferase activity | 2.1% (5/238) | 2.1 | 0.006772 | 0.034738 |
GO:0006325 | chromatin organization | 1.68% (4/238) | 2.43 | 0.006832 | 0.03488 |
GO:0008135 | translation factor activity, RNA binding | 1.26% (3/238) | 2.97 | 0.006944 | 0.035115 |
GO:0090079 | translation regulator activity, nucleic acid binding | 1.26% (3/238) | 2.97 | 0.006944 | 0.035115 |
GO:0051741 | 2-methyl-6-phytyl-1,4-benzoquinone methyltransferase activity | 0.42% (1/238) | 7.13 | 0.007105 | 0.035261 |
GO:0004108 | citrate (Si)-synthase activity | 0.42% (1/238) | 7.13 | 0.007105 | 0.035261 |
GO:0036440 | citrate synthase activity | 0.42% (1/238) | 7.13 | 0.007105 | 0.035261 |
GO:0006625 | protein targeting to peroxisome | 0.42% (1/238) | 7.13 | 0.007105 | 0.035261 |
GO:0030117 | membrane coat | 1.26% (3/238) | 2.95 | 0.007162 | 0.035377 |
GO:0071702 | organic substance transport | 3.78% (9/238) | 1.42 | 0.007237 | 0.035583 |
GO:0016755 | aminoacyltransferase activity | 2.1% (5/238) | 2.06 | 0.007439 | 0.03641 |
GO:0032446 | protein modification by small protein conjugation | 2.52% (6/238) | 1.83 | 0.007474 | 0.036414 |
GO:0043167 | ion binding | 15.55% (37/238) | 0.59 | 0.007515 | 0.036449 |
GO:0005524 | ATP binding | 8.82% (21/238) | 0.84 | 0.007643 | 0.036899 |
GO:0043487 | regulation of RNA stability | 0.84% (2/238) | 3.94 | 0.007785 | 0.037416 |
GO:0007033 | vacuole organization | 0.84% (2/238) | 3.92 | 0.007921 | 0.0379 |
GO:0019318 | hexose metabolic process | 1.26% (3/238) | 2.87 | 0.008441 | 0.040027 |
GO:0140142 | nucleocytoplasmic carrier activity | 0.84% (2/238) | 3.88 | 0.00843 | 0.040154 |
GO:0017076 | purine nucleotide binding | 11.34% (27/238) | 0.71 | 0.008554 | 0.040384 |
GO:0031468 | nuclear membrane reassembly | 0.42% (1/238) | 6.84 | 0.008677 | 0.040787 |
GO:0007063 | regulation of sister chromatid cohesion | 0.42% (1/238) | 6.78 | 0.00907 | 0.041006 |
GO:0071922 | regulation of cohesin loading | 0.42% (1/238) | 6.78 | 0.00907 | 0.041006 |
GO:1905634 | regulation of protein localization to chromatin | 0.42% (1/238) | 6.78 | 0.00907 | 0.041006 |
GO:0006396 | RNA processing | 3.36% (8/238) | 1.48 | 0.008812 | 0.04106 |
GO:0140096 | catalytic activity, acting on a protein | 9.66% (23/238) | 0.78 | 0.008777 | 0.041073 |
GO:0003682 | chromatin binding | 1.68% (4/238) | 2.32 | 0.008878 | 0.041185 |
GO:1903313 | positive regulation of mRNA metabolic process | 0.84% (2/238) | 3.83 | 0.009001 | 0.041219 |
GO:0032509 | endosome transport via multivesicular body sorting pathway | 0.84% (2/238) | 3.83 | 0.009001 | 0.041219 |
GO:0071985 | multivesicular body sorting pathway | 0.84% (2/238) | 3.83 | 0.009001 | 0.041219 |
GO:0010499 | proteasomal ubiquitin-independent protein catabolic process | 0.42% (1/238) | 6.72 | 0.009462 | 0.0426 |
GO:0070577 | lysine-acetylated histone binding | 0.42% (1/238) | 6.66 | 0.009855 | 0.043271 |
GO:0140033 | acetylation-dependent protein binding | 0.42% (1/238) | 6.66 | 0.009855 | 0.043271 |
GO:1990498 | mitotic spindle microtubule | 0.42% (1/238) | 6.66 | 0.009855 | 0.043271 |
GO:0032555 | purine ribonucleotide binding | 10.92% (26/238) | 0.71 | 0.009744 | 0.043502 |
GO:0006402 | mRNA catabolic process | 1.26% (3/238) | 2.79 | 0.009797 | 0.043557 |
GO:0045182 | translation regulator activity | 1.26% (3/238) | 2.79 | 0.009725 | 0.043601 |
GO:0065003 | protein-containing complex assembly | 2.1% (5/238) | 1.96 | 0.010004 | 0.043749 |
GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly | 0.42% (1/238) | 6.6 | 0.010247 | 0.044444 |
GO:0043461 | proton-transporting ATP synthase complex assembly | 0.42% (1/238) | 6.6 | 0.010247 | 0.044444 |
GO:0010565 | regulation of cellular ketone metabolic process | 0.84% (2/238) | 3.72 | 0.010348 | 0.0447 |
GO:0032553 | ribonucleotide binding | 10.92% (26/238) | 0.7 | 0.010742 | 0.045849 |
GO:1901565 | organonitrogen compound catabolic process | 2.52% (6/238) | 1.71 | 0.010791 | 0.045874 |
GO:0030163 | protein catabolic process | 1.68% (4/238) | 2.24 | 0.010721 | 0.04594 |
GO:0008023 | transcription elongation factor complex | 0.84% (2/238) | 3.69 | 0.01071 | 0.046081 |
GO:0071709 | membrane assembly | 0.42% (1/238) | 6.49 | 0.011031 | 0.046337 |
GO:0061709 | reticulophagy | 0.42% (1/238) | 6.49 | 0.011031 | 0.046337 |
GO:0040008 | regulation of growth | 0.84% (2/238) | 3.68 | 0.010973 | 0.046461 |
GO:0009894 | regulation of catabolic process | 1.26% (3/238) | 2.71 | 0.011326 | 0.04739 |
GO:0048586 | regulation of long-day photoperiodism, flowering | 0.42% (1/238) | 6.4 | 0.011814 | 0.049048 |
GO:0016514 | SWI/SNF complex | 0.42% (1/238) | 6.4 | 0.011814 | 0.049048 |